Fosun Pharma's Unit Signs Co-Development, Licensing Options Deal With Clavis Bio
ReutersDec 18, 2025 10:36 AM
Dec 18 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd 600196.SS:
SAYS UNIT SIGNS DEAL WITH CLAVIS BIO FOR CO-DEVELOPMENT AND EXCLUSIVE LICENSING OPTIONS
SAYS COULD RECEIVE UP TO $362.5 MILLION PER PROJECT IF CLAVIS BIO EXERCISES OPTION
Source text
Further company coverage: 600196.SS
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
TradingKey 2025 Markets Recap & Outlook | Wall Street Bullish on 2026: S&P 500 Forecast at 8,000 with AI Gains and Cyclical Stocks Soaring
TradingKey - As 2025 draws to a close, the U.S. stock market has delivered a series of exciting and astonishing moments. As 2026 approaches, major Wall Street banks remain confident about the outlook for U.S. equities, with an average forecast for the S&P 500 index reaching 7,500 points.TradingKey
22 hours ago
Ripple Price Prediction: Why Is XRP Price Falling? Can It Rise to $10 in the Future?
XRP has weakened this year due to profit-taking, capital outflows, and its correlation with Bitcoin. Despite support from potential spot ETFs and positive regulatory developments, significant market divergence, liquidity uncertainty, and macroeconomic uncertainty remain high. XRP's price is likely tTradingKey
23 hours ago
Elon Musk’s SpaceX Poised for Record-Breaking IPO: How Can Retail Investors Get In on the Action of Starlink Stock?
TradingKey - Elon Musk's rocket manufacturer SpaceX is expected to launch an IPO in 2026, with a target IPO valuation projected to reach $1.5 trillion. However, prior to its listing, the stock can only be traded in the private market, characterized by low information transparency and high capital baTradingKey
Fri, Dec 19
Amazon's $10 Billion Bet on OpenAI: A Win-Win Gamble?
TradingKey - According to a December 16 report by The Information, Amazon is in talks to invest at least $10 billion in OpenAI. As part of the proposed agreement, OpenAI plans to adopt Amazon's proprietary Trainium AI training chips. Will it be a win-win gamble?TradingKey
Wed, Dec 17
Tradingkey
